123 related articles for article (PubMed ID: 1656605)
1. Identification of the gene product encoded by the PstI repeats (IR4) of the Epstein-Barr virus genome.
Nuebling CM; Mueller-Lantzsch N
Virology; 1991 Nov; 185(1):519-23. PubMed ID: 1656605
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of an Epstein-Barr virus early antigen that is encoded by the NotI repeats.
Nuebling CM; Mueller-Lantzsch N
J Virol; 1989 Nov; 63(11):4609-15. PubMed ID: 2552144
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-specific DNase activity in nonproducer Raji cells after treatment with 12-o-tetradecanoylphorbol-13-acetate and sodium butyrate.
Ooka T; De Turenne M; De The G; Daillie J
J Virol; 1984 Feb; 49(2):626-8. PubMed ID: 6319766
[TBL] [Abstract][Full Text] [Related]
4. Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells.
Nutter LM; Grill SP; Li JS; Tan RS; Cheng YC
Cancer Res; 1987 Aug; 47(16):4407-12. PubMed ID: 3038311
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells.
Boos H; Berger R; Kuklik-Roos C; Iftner T; Mueller-Lantzsch N
Virology; 1987 Jul; 159(1):161-5. PubMed ID: 3037776
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a latent protein encoded by the large internal repeats and the BamHI Y fragment of the Epstein-Barr virus (EBV) genome.
Sauter M; Boos H; Hirsch F; Mueller-Lantzsch N
Virology; 1988 Oct; 166(2):586-90. PubMed ID: 2845663
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of Epstein-Barr virus early antigens by antitubulin agents in a latently infected human lymphoblastoid cell line.
Fujita J; Yoshida O; Tokuda H; Sugawara K; Ito Y
Experientia; 1985 Mar; 41(3):372-3. PubMed ID: 2982647
[TBL] [Abstract][Full Text] [Related]
8. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells.
Rowe M; Evans HS; Young LS; Hennessy K; Kieff E; Rickinson AB
J Gen Virol; 1987 Jun; 68 ( Pt 6)():1575-86. PubMed ID: 2438376
[TBL] [Abstract][Full Text] [Related]
10. Induction of EBV DNA demethylation and of EBV-specific transcription in Daudi cells treated with TPA and n-butyrate.
Collandre H; Guetard D; Montagnier L
Intervirology; 1984; 22(4):201-10. PubMed ID: 6096292
[TBL] [Abstract][Full Text] [Related]
11. Effect of activation of the Epstein-Barr virus genome on expression of B cell differentiation antigens of Burkitt's lymphoma lines.
Yokochi T; Inoue Y; Iwata H; Miyadai T; Kimura Y
Microbiol Immunol; 1988; 32(9):957-64. PubMed ID: 2850450
[TBL] [Abstract][Full Text] [Related]
12. Size and stability of the Epstein-Barr virus major internal repeat (IR-1) in Burkitt's lymphoma and lymphoblastoid cell lines.
Allan GJ; Rowe DT
Virology; 1989 Dec; 173(2):489-98. PubMed ID: 2556840
[TBL] [Abstract][Full Text] [Related]
13. Detection of 12-o-tetradecanoylphorbol-13-acetate-induced cellular proteins that compete with the Epstein-Barr virus nuclear antigen 1 (EBNA-1) for binding to a site within the Epstein-Barr virus oriP.
Nonoyama M; Wen LT; Tanaka A; Bradley G
Adv Exp Med Biol; 1990; 278():125-36. PubMed ID: 1963029
[No Abstract] [Full Text] [Related]
14. Effects of activated serum factor on the induction of Epstein-Barr virus antigens and cell differentiation.
Roubalová K; Anisimová E; Roubal J
Arch Virol; 1985; 85(1-2):85-94. PubMed ID: 2990391
[TBL] [Abstract][Full Text] [Related]
15. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
[TBL] [Abstract][Full Text] [Related]
16. Differential effect of TPA and n-butyrate on induction of Ii and EBV antigens in the P3HR-1 lymphoblastoid cell line.
Sairenji T; Spiro RC; Humphreys RE
Hematol Oncol; 1984; 2(4):381-9. PubMed ID: 6098544
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus nuclear antigen (EBNA): size polymorphism of EBNA 1.
Allday MJ; MacGillivray AJ
J Gen Virol; 1985 Jul; 66 ( Pt 7)():1595-600. PubMed ID: 2991431
[TBL] [Abstract][Full Text] [Related]
18. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of the cooperative effect between inducers of Epstein-Barr virus antigen synthesis.
Bauer G
J Gen Virol; 1983 Jun; 64 (Pt 6)():1337-46. PubMed ID: 6304236
[TBL] [Abstract][Full Text] [Related]
20. Chemically purified serum factor can induce both Epstein-Barr virus antigen synthesis and cell differentiation.
Anisimová E; Roubalová K; Bauer G; Roubal J
Arch Virol; 1987; 94(3-4):309-14. PubMed ID: 3034214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
